[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342098-105":59,"doc-detail-342098-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-and-therapeutic-potential-of-gene-profiles-related-to-tertiary-lymphoid-structures-in-colorectal-cancer","Prognostic and therapeutic potential of gene profiles related to tertiary lymphoid structures in colorectal cancer","","This study investigates the prognostic and therapeutic value of tertiary lymphoid structures (TLS) in colorectal carcinoma, where comprehensive analysis has been limited. A novel TLS quantification framework was developed, generating a TLS score within the Tumor Immune Microenvironment using single-cell sequencing. TLS-related genes were analyzed across 1,184 COADREAD cases from TCGA and GEO, revealing two molecular subtypes. Gene-set scoring predicted immunotherapy outcomes in two independent cohorts, linking high scores to a hot immune phenotype and improved response, with key genes supporting tumor progression and PD-L1 expression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-and-therapeutic-potential-of-gene-profiles-related-to-tertiary-lymphoid-structures-in-colorectal-cancer/342098/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-and-therapeutic-potential-of-gene-profiles-related-to-tertiary-lymphoid-structures-in-colorectal-cancer/342098.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study regarding tertiary lymphoid structures (TLS)?","Question",{"text":112,"@type":113},"To develop and validate a TLS quantification approach that can predict prognosis and therapeutic response in colorectal carcinoma, supported by a detailed TLS landscape analysis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the TLS score constructed and validated?",{"text":117,"@type":113},"The TLS score was formulated using gene set variation analysis (GSVA) within the Tumor Immune Microenvironment, then its ability to predict immunotherapy outcomes was validated in two independent cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about patient immune phenotypes and immunotherapy efficacy?",{"text":121,"@type":113},"Patients with high TLS scores showed a “hot” immune phenotype, which correlated with enhanced immunotherapy efficacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342098,1790172758,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Submitted 25 June 2024  \nAccepted 4 October 2024  \nPublished 31 October 2024  \nCorresponding author  \nYufang Bao, [YufangBaosarly@126.com](YufangBaosarly@126.com)[ ](YufangBaosarly@126.com)Academic editor  \nEmanuela Felley-Bosco Additional Information and Declarations can be found on page 25  \nDOI 10.7717/peerj.18401  \nCopyright 2024 Yu et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nPrognostic and therapeutic potential of gene proﬁles related to tertiary lymphoid structures in colorectal cancer  \nJinglu Yu 1, Yabin Gong2, Xiaowei Huang3 and Yufang Bao 1  \n1 PuDong Traditional Chinese Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Pudong New Area, China  \n2 Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \n3 Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \nABSTRACT  \nThe role of tertiary lymphoid structures (TLS) in oncology is gaining interest, particularly in colorectal carcinoma, yet a thorough analysis remains elusive. This study pioneered a novel TLS quantiﬁcation system for prognostic and therapeutic response prediction in colorectal carcinoma, alongside a comprehensive depiction of the TLS landscape. Utilizing single-cell sequencing, we established a TLS score within the Tumor Immune Microenvironment (TIME) . Analysis of tertiary lymphoid structure-related genes (TLSRGs) in 1,184 patients with colon adenocarcinoma/ rectum adenocarcinoma (COADREAD) from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases led to the identiﬁcation of two distinct molecular subtypes. Differentially expressed genes (DEGs) further segregated these patients into gene subtypes. A TLS score was formulated using gene set variation analysis (GSVA) and its efﬁcacy in predicting immunotherapy outcomes was validated in two independent cohorts. High-scoring patients exhibited a ‘hot’immune phenotype, correlating with enhanced immunotherapy efﬁcacy. Key genes in our model, including C5AR1, APOE, CYR1P1, and SPP1, were implicated in COADREAD cell proliferation, invasion, and PD-L1 expression. These insights offera novel approach to colorectal carcinoma treatment, emphasizing TLS targeting as a potential anti-tumor strategy.  \nSubjects Bioinformatics, Oncology  \nKeywords Tertiary lymphoid structures, Colon adenocarcinoma/rectum adenocarcinoma, Therapeutic potential  \nINTRODUCTION  \nColorectal cancer, a predominant gastrointestinal malignancy, ranks third in  \ncancer-related mortality globally. The survival rates at 5 years hover around 65%(Morgan et al., 2023; Siegel et al., 2023). Surgical removal is the cornerstone for treating early-stage colorectal cancer, while advanced stages often beneﬁt from an integrated approach of chemotherapy and targeted therapies (Morris et al., 2023) . The advent of immune checkpoint inhibitors (ICIs) has marked a revolutionary shift in oncological therapeutics, offering signiﬁcant clinical advantages for patients (André et al., 2020;  \nHow to cite this article Yu J, Gong Y, Huang X, Bao Y. 2024. Prognostic and therapeutic potential of gene proﬁles related to tertiary lymphoid structures in colorectal cancer. PeerJ 12:e18401 DOI 10.7717/peerj.18401  \nLudford et al., 2023) . Yet, the response to ICIs is limited to a small patient subset (Gurjao et al., 2019; Marabelle et al., 2020), underscoring the urgent need for biomarker research. This research is essential for reﬁning patient selection and developing strategies to overcome immune resistance.  \nHistorically, biomarker investigations have predominantly relied on RNA sequencing (RNA-Seq) from whole tumor tissues (Thind et al., 2021), providing a collective genetic snapshot of diverse cell populations. Unfortunately, biomarkers identiﬁed through this method have demonstrated restricted predictive capability. The emergence of si","cbCaicx4ZORlHOVn","https://ap.wps.com/l/cbCaicx4ZORlHOVn","pdf",39331969,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main goal of the study regarding tertiary lymphoid structures (TLS)?\",\"answer\":\"To develop and validate a TLS quantification approach that can predict prognosis and therapeutic response in colorectal carcinoma, supported by a detailed TLS landscape analysis.\"},{\"question\":\"How was the TLS score constructed and validated?\",\"answer\":\"The TLS score was formulated using gene set variation analysis (GSVA) within the Tumor Immune Microenvironment, then its ability to predict immunotherapy outcomes was validated in two independent cohorts.\"},{\"question\":\"What did the study find about patient immune phenotypes and immunotherapy efficacy?\",\"answer\":\"Patients with high TLS scores showed a “hot” immune phenotype, which correlated with enhanced immunotherapy efficacy.\"}]","Prognostic and therapeutic potential of gene profiles related to tertiary lymphoid structures in colorectal cancer | PDF",1790045192,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdad6de3f77ca8168a0221e59d180aba.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d276ceca4ffea91059dddbbcd2887076.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/731cb86e9eb62b65be0b00150bba0c5c.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abe67ff321bc6defd92ad7bb5fd5afe4.webp",980,1268]